Image (4bd586ae Be2f 4cd9 B465 4912084e4cca 01)
Prochlorperazine Maleate Tablet
Product Images NDC 70771-1697
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Maleate (NDC 70771-1697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (4bd586ae Be2f 4cd9 B465 4912084e4cca 02)
This is a description of Prochlorperazine Maleate tablets containing 5 mg of Prochlorperazine. The tablets are coated and are contained in a child-resistant package with 100 tablets per container. The tablets are prescribed by a physician and should be stored in a light-resistant container at temperatures between 20°C to 25°C. The manufacturer is Cadia Healthcare Ltd based in Ahmedaba, India. The text also includes information on the size of the tablet and its unique identifier code.*
Figure (4bd586ae Be2f 4cd9 B465 4912084e4cca 03)
This is a package of Prochlorperazine Maleate Tablets, USP with 100 tablets in it. Each tablet has 10 mg of Prochlorperazine Maleate, USP. The package comes with a safety closure and is child-resistant. The usual dosage is 100-40 g daily, and more information can be found in the package insert. The tablets should be dispensed in a light-resistant container as defined in the USP and stored at 20° - 25°C. Mig. by Cadila Healthcare Ltd, Ahmedabad, India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
